$CTEV News

Barclays Maintains Overweight on Claritev, Raises Price Target to $40

Wells Fargo Maintains Equal-Weight on Claritev, Raises Price Target to $30

Claritev Analysts Raise Their Forecasts Following Q2 Earnings

Citigroup Maintains Buy on Claritev, Raises Price Target to $45

Canaccord Genuity Maintains Buy on Claritev, Raises Price Target to $43

Claritev Q2 Earnings Call Highlights

Claritev Corporation 2026 Q2 - Results - Earnings Call Presentation

Claritev Corp (CTEV) (Q2 2026) Earnings Call Highlights: Record Bookings and AI-Driven Growth ...

Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript

Claritev Beats Second-Quarter Expectations and Raises Full-Year Guidance

Claritev (NYSE:CTEV) Beats Q2 Estimates and Raises Full-Year Guidance

Claritev Corporation Reports Second Quarter 2026 Results

Claritev Raises FY2026 Sales Guidance from $985.000M-$1.000B to $1.000B-$1.020B vs $993.511M Est

Claritev Q2 EPS $(3.49) Beats $(4.21) Estimate, Sales $257.478M Beat $244.813M Estimate

Claritev Corporation Announces Participation in Canaccord Genuity 46th Annual Growth Conference

Claritev Demonstrates Market Leadership as Federal No Surprises Act Disputes Reach Record Levels

Claritev™ and SAVVI Financial® Collaborate to Deliver the Next Generation of Healthcare Benefit Decision Support

Claritev Adopts CodeTogether's AITrax to Bring Greater Measurement and Accountability to AI-Assisted Development

Canaccord Genuity Maintains Buy on Claritev, Raises Price Target to $37

Sun Life U.S. and Claritev work to boost efficiency of supplemental health benefits